Cost-Effectiveness Of Cervical Cancer Screening Methods In Low- And Middle-Income Countries: A Systematic Review

Feb 6, 2017 - 12:00pm to 1:00pm
700-828 W. 10 Ave., VGH Research Pavilion
Alex Mezei

The incidence of cervical cancer in low- and middle-income countries (LMICs) is five times higher than that observed in high-income countries (HICs). This discrepancy is largely attributed to the implementation of cytology-based screening programmes in HICs. However, due to reduced health system infrastructure requirements, HPV testing (self- and provider-collected), and visual inspection with acetic acid (VIA) have been proposed as alternatives that may be better suited to LMICs. This presentation will describe the methods, results and implications of a systematic review on the cost-effectiveness of cervical cancer screening methods in LMICs. Specific learning objectives that will be addressed are as follows:

  1. Describe the global burden of cervical cancer
  2. Compare the cost-effectiveness of cervical cancer screening methods in LMICs
  3. Identify the parameters that are driving cost-effectiveness ratios
  4. Describe areas of ongoing research